Endovascular Management in Patients with Acute Basilar Artery Obstruction: Low-Dose Intra-Arterial Urokinase and Mechanical Clot Disruption

Abstract

Mechanical clot disruption for the treatment of acute basilar artery occlusion (BAO) is known to provide a benefit. We aimed to determine the safety, recanalization rate and time-to-flow restoration of mechanical clot disruption and low dose urokinase (UK) infusions for the treatment of patients with acute BAO.

Between June 2006 and June 2010, 21 patients with acute BAO underwent endovascular treatment that included angioplasty or stent placement. The time to treatment, duration of the procedure, dose of urokinase (UK), recanalization rates and symptomatic hemorrhages were analyzed. Clinical outcome measures were assessed at admission and at the time of discharge using the National Institutes of Health Stroke Scale (NIHSS) score and at three months after treatment using the modified Rankin Score (mRS).

On admission, the median NIHSS score was 13.2. Median time from symptom onset to arrival at hospital was 356 minutes, and median time from symptom onset to intraarterial thrombolysis (IAT) was 49 minutes. We used the following interventional treatment regimens: Intraarterial (IA) UK and a minimal mechanical procedure (n=14), IA UK with angioplasty (n=1), IA UK with angioplasty and stent placement (n=3) and IA UK with HyperForm (n=3). The recanalization (thrombolysis in cerebral ischemia grade II or III) rate was 90.5% (19/21). There was symptomatic hemorrhage in one patient (4.8%). The median NIHSS score at discharge was 6.3. The three-month outcome was favorable (mRS: 0–2) for 14 patients (66.7%) and poor (mRS: 3–6) for seven patients (33.3%). The overall mortality at three months was 14.3% (three patients died).

Low-dose IAT with mechanical clot disruption is a safe and effective treatment for treatment for acute BAO.

Keywords

acute stroke endovascular treatment thrombolysis

Get full access to this article

View all access options for this article.

References

Archer

Horenstein

. Basilar artery occlusion: Clinical and radiological correlation. Stroke. 1977; 8: 383–390.

Hacke

Zeumer

Ferbert

. Intra-arterial thrombolytic therapy improves outcome in patients with acute vertebrobasilar occlusive disease. Stroke. 1988; 19: 1216–1222.

Brandt

von Kummer

Muller-Kuppers

. Thrombolytic therapy of acute basilar artery occlusion. Variables affecting recanalization and outcome. Stroke. 1996; 27: 875–881.

Schulte-Altedorneburg

Hamann

Mull

. Outcome of acute vertebrobasilar occlusions treated with intra-arterial fibrinolysis in 180 patients. Am J Neuroradiol. 2006; 27: 2042–2047.

Lindsberg

Mattle

. Therapy of basilar artery occlusion: A systematic analysis comparing intra-arterial and intravenous thrombolysis. Stroke. 2006; 37: 922–928.

Ferbert

Bruckmann

Drummen

. Clinical features of proven basilar artery occlusion. Stroke. 1990; 21: 1135–1142.

Glass

Hennessey

Pazdera

. Outcomes at 30 days in the New England Medical Center Posterior Circulation Registry. Arch Neurol. 2002; 59: 369–376.

Arnold

Nedeltchev

Schroth

. Clinical and radiological predictors of recanalisation and outcome of 40 patients with acute basilar artery occlusion treated with intra-arterial thrombolysis. J Neurol Neurosurg Psychiatry. 2004; 75: 857–862.

Eckert

Kucinski

Pfeiffer

. Endovascular therapy of acute vertebrobasilar occlusion: Early treatment onset as the most important factor. Cerebrovasc Dis. 2002; 14: 42–50.

10.

Levy

Firlik

Wisniewski

. Factors affecting survival rates for acute vertebrobasilar artery occlusions treated with intra-arterial thrombolytic therapy: A meta-analytical approach. Neurosurgery. 1999; 45: 539–548.

11.

Huemer

Niederwieser

Ladurner

. Thrombolytic treatment for acute occlusion of the basilar artery. J Neurol Neurosurg Psychiatry. 1995; 58: 227–228.

12.

Cross

3rd Moran

Akins

. Relationship between clot location and outcome after basilar artery thrombolysis. Am J Neuroradiol. 1997; 18: 1221–1228.

13.

Sliwka

Mull

Stelzer

. Long-term follow-up of patients after intraarterial thrombolytic therapy of acute vertebrobasilar artery occlusion. Cerebrovasc Dis. 2001; 12: 214–219.

14.

Alexandrov

Demchuk

Felberg

. High rate of complete recanalization and dramatic clinical recovery during tPA infusion when continuously monitored with 2-MHz transcranical Doppler monitoring. Stroke. 2000; 31: 610–614.

15.

Alexandrov

Grotta

. Arterial reocclusion in stroke patients treated with intravenous tissue plasminogen activator. Neurology. 2002; 59: 862–867.

16.

Higashida

Furlan

Roberts

. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke. Stroke. 2003; 34: e109–e137.

17.

Lindsberg

Soinne

Tatlisumak

. Long-term outcome after intravenous thrombolysis of basilar artery occlusion. JAMA. 2004; 292: 1862–1866.

18.

Noser

Shaltoni

Hall

. Aggressive mechanical clot disruption. A safe adjunct to thrombolytic therapy in acute stroke? Stroke. 2005; 36: 292–296.

19.

Qureshi

Siddiqui

Suri

. Aggressive mechanical clot disruption and low-dose intra-arterial third-generation thrombolytic agent for ischemic stroke: A prospective study. Neurosurgery. 2002; 51: 1319–1329.

20.

Yoon

Park

Cho

. Low-dose intra-arterial urokinase and aggressive mechanical clot disruption for acute ischemic stroke after failure of intravenous thrombolysis. Am J Neuroradiol. 2010; 31: 161–164.

21.

Vora

Gupta

Thomas

. Factors predicting hemorrhagic complications after multimodal reperfusion therapy for acute ischemic stroke. Am J Neuroradiol. 2007; 28: 1391–1394.

22.

Brekenfeld

Remonda

Nedeltchev

. Sympatomatic intracranial hemorrhage after intra-arterial thrombolysis in acute ischemic stroke: Assessment of 294 patients treated with urokinase. J Neurol Neurosurg Psychiatry. 2007; 78: 280–285.

23.

Eckert

Koch

Thomalla

. Aggressive therapy with intravenous abciximab and intra-arterial rt-PA and additional pta/stenting improves clinical outcome in acute vertebrobasilar occlusion: Combined local fibrinolysis and intravenous abciximab in acute vertebrobasilar stroke treatment (fast): Result of a multicenter study. Stroke. 2005; 36: 1160–1165.

24.

Nagel

Schellinger

Hartmann

. Therapy of acute basilar artery occlusion: Intraarterial thrombolysis alone vs bridging therapy. Stroke. 2009; 40: 140–146.

25.

Pfefferkorn

Mayer

Opherk

. Staged escalation therapy in acute basilar artery occlusion: Intravenous thrombolysis and on-demand consecutive endovascular mechanical thrombectomy: Preliminary experience in 16 patients. Stroke. 2008; 39: 1496–1500.